Early response cytokines and innate immunity: Essential roles for TNF receptor 1 and type I IL-1 receptor during Escherichia coli pneumonia in mice

Journal of Immunology

Volumn 166, Issue 6, 2001, Pages 4042-4048

  Mizgerd, J P ^a   Spieker, M R ^a   Doerschuk, C M ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; MACROPHAGE INFLAMMATORY PROTEIN 2; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL PNEUMONIA; CONTROLLED STUDY; EDEMA; ESCHERICHIA COLI; IMMUNITY; LUNG LAVAGE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 0035869514     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.6.4042     Document Type: Article

References (46)

1. The tumor necrosis factor ligand and receptor families
2. Interleukin-1
3. Role of cytokines in pulmonary antimicrobial host defense
4. Functional characterization of the rat chemokine KC and its importance in nantrophil recruitment in a rat model of pulmonary inflammation
5. Functional characterization of rat chemokine macrophage inflammatory prorein-2
6. Role for macrophage inflammatory protein-2 in lipopolysaccharide-induced lung injury in rats
7. Cooperative interaction of nuclear factor-κB- and cis-regulatory enhancer binding protein-like factor binding elements in activating the interleukin-8 gene by pro-inflammatory cytokines
8. Two structurally distinct κB sequence motifs cooperatively control LPS-induced KC gene transcription in mouse macrophages
9. Transcriptional regulation of endothelial cell adhesion molecules: NF-κB and cytokine-inducible enhancers
10. Tumor necrosis factor a (TNF-α)-induced cell adhesion to human endothelial cells is under dominant control of one TNF receptor type, TNF-R55
11. Dissociation of TNF-α cytotoxic and proinflammatory activities by p55 receptor- and p75 receptor-selective TNF-α mutants
12. Self-association of the death domains of the p55 tumor necrosis factor (TNF) receptor and Fas/APO1 prompts signaling for, TNF and Fas/APO1 effects
13. Tumor necrosis factor receptor p75 mediates cell-specific activation of nuclear factor κB and induction of human cytomegalovirus enhancer
14. TRAF2-mediated activation of NF-κB by TNF receptor 2 and CD40
15. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor
16. Tumor necrosis factors (Tnfr) in mouse fibroblasts deficient in Tnfr1 or Tnfr2 are signaling competent and activate the mitogen-activated protein kinase pathway with differential kinetics
17. Critical role of 55-kilodalton TNF receptor in TNF-induced adhesion molecule expression and leukocyte organ infiltration
18. Mice lacking the tumour necrosis factor receptor I are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes
19. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection
20. Tumor necrosis factor-α is required in the protective immune response against Mycobacterium tuberculosis in mice
21. TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation
22. The two interleukin-1 receptors play different roles in IL-1 actions
23. Multiple signals converging on NF-κB
24. The Toll-receptor family and control of innate immunity
25. Phenotypic and functional characterization of mice that lack the type 1 receptor for IL-1
26. Neutrophil emigration in the skin, lungs, and peritoneum: Different requirements for CD11/CD18 revealed by CD18-deficient mice
27. Roles of tumor necrosis factor signaling during murine Escherichia coli pneumonia in mice
28. NF-κB and Rel proteins: Evolutionarily conserved mediators of immune responses
29. Sequential changes of inflammatory and nutritional markers in patients with community-acquired pneumonia
30. Daily variation in circulating cytokines and acute-phase proteins correlates with clinical and laboratory indices in community-acquired pneumonia
31. Structural features of the human C3 gene: Intron/exon organization, transcriptional start site, and promoter region sequence
32. NF-κB and C/EBP transcription factor families synergistically function in mouse serum amyloid A gene expression induced by inflammatory cytokines
33. Complement component C3 production in IL-1β-stimulated human intestinal epithelial cells is blocked by NF-κB inhibitors and by transfection with Ser 32/36 mutant IκBα
34. Acidophilic macrophage pneumonia in laboratory mice
35. IL-5 is required for eosinophil recruitment, crystal deposition, and mononuclear cell recruitment during a pulmonary Cryptococcus neoformans infection in genetically susceptible mice (C57BL/6)
36. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production
37. Biochemical characterization of endogenously formed eosinophilic crystals in the lungs of mice
38. Genomic cloning and promoter analysis of macrophage inflammatory protein (MIP)-2, MIP-1α, and MIP-1β, members of the chemokine superfamily of proinflammatory cytokines
39. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signaling
40. Human Toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharide
41. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene
42. Endotoxin-tolerant mice have mutations in Toll-like receptor 4
43. Serum amyloid A is a chemoattractant: Induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes
44. Impaired mast cell-dependent natural immunity in complement C3-deficient mice
45. A novel function of serum amyloid A: A potent stimulus for the release of tumor necrosis factor-α, interleukin-1β, and interleukin-8 by human blood neutrophils
46. Serum amyloid A is an activator of PMN antimicrobial functions: Induction of degranulation, phagocytosis, and enhancement of anti-Candida activity